Check Cap Ltd (CHEK) Given Average Recommendation of “Strong Buy” by Analysts
Shares of Check Cap Ltd (NASDAQ:CHEK) have been assigned an average broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy rating.
Analysts have set a 12-month consensus price target of $5.00 for the company, according to Zacks. Zacks has also given Check Cap an industry rank of 158 out of 265 based on the ratings given to related companies.
A number of equities analysts have commented on the company. Zacks Investment Research downgraded Check Cap from a “buy” rating to a “hold” rating in a research note on Wednesday, July 20th. Maxim Group lifted their target price on Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, August 1st.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/19/check-cap-ltd-chek-given-average-recommendation-of-strong-buy-by-analysts.html
Shares of Check Cap (NASDAQ:CHEK) traded up 2.2363% during mid-day trading on Wednesday, hitting $1.8607. 6,102 shares of the company’s stock traded hands. Check Cap has a 1-year low of $0.97 and a 1-year high of $3.72. The stock has a 50 day moving average price of $1.99 and a 200-day moving average price of $1.98. The stock’s market cap is $22.80 million.
Check Cap Company Profile
Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Check Cap Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap Ltd and related companies with MarketBeat.com's FREE daily email newsletter.